DeepVerge (DVRG) Share Price, News & Analysis

Company Overview

DeepVerge plc, an environmental and life science artificial intelligent company, develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus, and toxins. The company offers Labskin, a commercially available lab-grown, full thickness human skin to support product research and development activities in the cosmetic, personal care, medical device, and pharmaceutical sectors; Rinocloud, a data infrastructure as a service that delivers secure intelligent store, share and search, encryption, and infrastructure technologies; and skin trust club, a skin health tracking using advanced sequencing, bioinformatics, and AI algorithms. It also provides regulated environmental toxicology services; human skin equivalent platform to validate and verify the safety and impact on client products for regulatory authority approval; AI and microbiome platform to facilitate clinical trials for skincare companies and remote test-kits for consumer skin; and monitoring and data analytics platform for real-time detection and identification of pathogens in water and wastewater treatment plants, drinking water, rivers, lakes, and reservoirs. In addition, the company offers a range of skin care products and cannabinoid oils. It operates in the United Kingdom, rest of Europe, the United States, and internationally. The company was formerly known as Integumen Plc and changed its name to DeepVerge plc in October 2020. The company was incorporated in 2016 and is headquartered in Malahide, Ireland.

Key Stats

• Today's Range: N/A
• 50-Day Range: 0.15 to 0.15
• 52-Week Range: N/A
• Volume: 100 shs
• Average Volume: 9.94 million shs
• Market Capitalization: £1.14 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DVRG Stock Analysis - Frequently Asked Questions

How do I buy shares of DeepVerge?

Shares of DVRG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of DeepVerge own?

Based on aggregate information from My MarketBeat watchlists, some other companies that DeepVerge investors own include Coats Group (COA), genedrive (GDR), Rolls-Royce Holdings plc (RR.L), Aviva (AV), Barclays (BARC), B&M European Value Retail (BME) and BP (BP).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: LON:DVRG
• CUSIP: N/A
• CIK: N/A
• Web: www.deepverge.com
• Phone: 44 20 3239 3716
• Fax: N/A
• Employees: 73
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-2,460,000.00
• Net Margins: -19.81%
• Pretax Margin: N/A
• Return on Equity: -10.27%
• Return on Assets: -5.56%

Debt

• Debt-to-Equity Ratio: 27.76
• Current Ratio: 1.38
• Quick Ratio: 1.00

Sales & Book Value

• Annual Sales: £12.41 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 3.60
• Book Value: GBX 10 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 760,460,000
• Free Float: N/A
• Market Cap: £1.14 million
• Optionable: Not Optionable
• Beta: 1.07